Atriyal Fibrilasyonda Atrioventriküler (AV) Nod Ablasyonu ve Kardiyak Resenkronizasyon Tedavisi
Özet
Referanslar
H. Zulkifly, G.Y.H. Lip, D.A. Lane, Epidemiology of atrial fibrillation. The International Journal of Clinical Practice. 2018; e13070. DOI:10.1111/ijcp.13070.
Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. The American Journal of Cardiology. 2003;91:2D–8D. DOI: 10.1016/s0002-9149(02)03373-8.
Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;91:2D–8D. DOI: 10.1161/01.CIR.0000072767.89944.6E.
Deedwania PC, Lardizabal JA. Atrial fibrillation in heart failure: a comprehensive review. The American Journal of Medicine. 2010; 123: 198–204. DOI: 10.1016/j.amjmed.2009.06.033.
Wood MA, Brown-Mahoney C, Kay GN, et al. Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis. Circulation. 2000;101:1138-44 DOI: 10.1161/01.cir.101.10.1138.
Lara Kugler, Susanne Markendorf , Marta Bachmann, et al. Cardiac resynchronization therapy in the presence of total atrioventricular block reduces long-lasting atrial fibrillation episodes. Journal of Arrhythmia. 2022; Sep 7;38(5):723-729. DOI: 10.1002/joa3.12776.
Finn Akerström, Moisés Rodríguez Mañero, Marta Pachón, et al. Atrioventricular Junction Ablation In Atrial Fibrillation: Choosing The Right Patient And Pacing Device. Journal of Atrial Fibrillation. 2015; Aug 31;8(2):1253. DOI: 10.4022/jafib.1253.
Balijepalli RC, Lokuta AJ, Maertz NA, et al. Depletion of T-tubules and specific subcellular changes in sarcolemmal proteins in tachycardia-induced heart failure. Cardiovascular Research. 2003;59:67-77. DOI: 10.1016/s0008-6363(03)00325-0.
Selby DE, Palmer BM, LeWinter MM, et al. Tachycardia-induced diastolic dysfunction and resting tone in myocardium from patients with a normal ejection fraction. Journal of the American College of Cardiology. 2011;58:147-54 DOI: 10.1016/j.jacc.2010.10.069.
Gupta S, Figueredo VM. Tachycardia mediated cardiomyopathy: pathophysiology, mechanisms, clinical features and management. International Journal of Cardiology. 2014;172:40-6.
Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. The New England Journal of Medicine. 2002;347:1825–1833. DOI: 10.1056/021328.
Roy D, Talajic M, Nattel S, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. The New England Journal of Medicine. 2008;358:2667–2677. DOI: 10.1056/NEJMoa0708789.
Carlsson J, Miketic S, Windeler J, et al. Randomized trial of rater-control versus rhythm-control in persistent atrial fibrillation. Journal of the American College of Cardiology. 2003;41:1690. DOI: 10.1016/s0735-1097(03)00332-2.
Khan MN, Jais P, Cummings J, et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. The New England Journal of Medicine. 2008;359:1778–1785. DOI: 10.1056/NEJMoa0708234.
Marrouche NF, Brachmann J, Andresen D, et al. Catheter ablation for atrial fibrillation with heart failure. The New England Journal of Medicine. 2018;378:417–427. DOI: 10.1056/NEJMc1806519.
Cleland JGF, Keshavarzi F, Pellicori P, et al. Case selection for cardiac resynchronization in atrial fibrillation. Heart Failure Clinics. 2013;9: 461–74. DOI: 10.1016/j.hfc.2013.07.001
Erik O Udo 1, Nicolaas P A Zuithoff, Norbert M Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm. 2012 May;9(5):728-35. DOI: 10.1016/j.hrthm.2011.12.014.
Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. The American Journal of Cardiology. 2003;91:2D–8D.
Hikmet Yorgun, Uğur Canpolat, Yusuf Ziya Şener, et al. Acute and long-term outcomes of left-sided atrioventricular node ablation in patients with atrial fibrillation. Journal of Interventional Cardiac Electrophysiology. 2020 Dec;59(3):527-533. doi: 10.1007/s10840-019-00642-8.
Chatterjee NA, Upadhyay GA, Ellenbogen KA, et al. Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis and systematic review. Circulation: Arrhythmia and Electrophysiology. 2012;5:68–76. DOI: 10.1161/CIRCEP.111.967810.
Brignole M, Gianfranchi L, Menozzi C, et al. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study. Circulation. 1997;96:2617–2624. DOI: 10.1161/01.cir.96.8.2617.
Gasparini M, Leclercq C, Lunati M, et al. Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry). JACC Heart Failure. 2013 Dec;1(6):500-7.
Gasparini M, Auricchio A, Regoli F, et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. Journal of the American College of Cardiology. 2006;48:734–743. DOI: 10.1016/j.jacc.2006.03.056.
Scheinman MM, Morady F, Hess DS, et al. Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. The Journal of the American Medical Association. 1982;248:851-5.
Huang SK, Bharati S, Graham AR, et al. Closed chest catheter desiccation of the atrioventricular junction using radiofrequency energy-a new method of catheter ablation. Journal of the American College of Cardiology. 1987;9:349-58.
Sousa J, El-Atassi R, Rosenheck S, et al. Radiofrequency catheter ablation of the atrioventricular junction from the left ventricle. Circulation. 1991;84:567–571. DOI: 10.1161/01.cir.84.2.567.
Marshall HJ, Griffith MJ. Ablation of the atrioventricular junction: Technique, acute and long-term results in 115 consecutive patients. Europace. 1999; 1: 26–29. DOI: 10.1053/eupc.1998.0004.
Dilesh Patel, Emile G. Daoud Atrioventricular Junction Ablation for Atrial Fibrillation. Heart Failure Clinics. 12 2016;245–255.
Proclemer A, Facchin D, Pagnutti C, et al. Safety of pacemaker implantation prior to radiofrequency ablation of atrioventricular junction in a single session procedure. Pacing and Clinical Electrophysiology. 2000;23:998-1002. DOI: 10.1111/j.1540-8159.2000.tb00887.
Geelen P, Brugada J, Andries E, et al. Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction. Pacing and Clinical Electrophysiology. 1997;20(2 Pt 1):343–8.
Wang RX, Lee HC, Hodge DO, et al. Effect of pacing method on risk of sudden death after atrioventricular node ablation and pacemaker implantation in patients with atrial fibrillation. Heart Rhythm. 2013;10(5):696–701 DOI: 10.1016/j.hrthm.2013.01.021.
Szili-Torok T, Kimman GP, Theuns D, et al. Deterioration of left ventricular function following atrio-ventricular node ablation and right ventricular apical pacing in patients with permanent atrial fibrillation. Europace. 2002;4:61–65. DOI:10.1053/eupc.2001.0212.
Tops LF, Schalij MJ, Holman ER, et al. Right ventricular pacing can induce ventricular dyssynchrony in patients with atrial fibrillation after atrioventricular node ablation. Journal of the American College of Cardiology. 2006;48:1642–1648. DOI:10.1016/j.jacc.2006.05.072.
Rahul N Doshi, Emile G Daoud, Christopher Fellows, et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). Journal of cardiovascular electrophysiology. 2005 Nov;16(11):1160-5.
Suneet Mittal, Dan L Musat, Michael H Hoskins, et al. Clinical Outcomes After Ablation of the AV Junction in Patients With Atrial Fibrillation: Impact of Cardiac Resynchronization Therapy. Journal of the American Heart Association. 2017 Nov 27;6(12):e007270. DOI: 10.1161/JAHA.117.007270.
Kan Dong, Win-Kuang Shen, Brian D Powell, et al. Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy. Heart Rhythm. 2010Sep;7(9):1240-5. DOI: 10.1016/j.hrthm.2010.02.011.
Michele Brignole, Francesco Pentimalli, Pietro Palmisano, et al. AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. European heart journal. 2021 Dec 7;42(46):4731-4739. DOI: 10.1093/eurheartj/ehab569.
Michele Brignole, Evgeny Pokushalov, Francesco Pentimalli, et al. A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS. European heart journal. 2018 Dec 1;39(45):3999-4008. DOI: 10.1093/eurheartj/ehy555.
Dickstein K, Normand C, Auricchio A, et al. CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients—who is doing what to whom and how? European Journal of Heart Failure. 2018;20:1039–1051. DOI: 10.1002/ejhf.1142.
Santini M, Gasparini M, Landolina M, et al. Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators. Journal of the American College of Cardiology. 2011;57:167–172. DOI: 10.1016/j.jacc.2010.08.624.
Mustafa U, Atkins J, Mina G, et al. Outcomes of cardiac resynchronisation therapy in patients with heart failure with atrial fibrillation: a systematic review and meta-analysis of observational studies. Open Heart. 2019;6:1–12 DOI: 10.1136/openhrt-2018-000937
Ousdigian KT, Borek PP, Koehler JL, et al. The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality. Circulation. Arrhythmia and electrophysiology. 2014;7:370–376. DOI: 10.1161/CIRCEP.113.001212.
Kamath GS, Cotiga D, Koneru JN, et al. The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy. Journal of the American College of Cardiology. 2009;53:1050–1055.
Antonio Hernández-Madrid, Domenico Facchin, Ruth Nicholson Klepfer, et al. Device pacing diagnostics overestimate effective cardiac resynchronization therapy pacing results of the hOLter for Efficacy analysis of CRT (OLÉ CRT) study. Heart Rhythm. 2017Apr;14(4):541-547. DOI: 10.1016/j.hrthm.2017.01.022.
Yoga Waranugraha, Ardian Rizal, Dion Setiawan, et al. The Benefit of Atrioventricular Junction Ablation for Permanent Atrial Fibrillation and Heart Failure Patients Receiving Cardiac Resynchronization Therapy: An Updated Systematic Review and Meta-analysis. Indian Pacing and Electrophysiology Journal. 2021 Mar-Apr;21(2):101-111. DOI: 10.1016/j.ipej.2020.12.005.
Yin J, Hu H, Wang Y, et al. Effects of atrioventricular nodal ablation on permanent atrial fibrillation patients with cardiac resynchronization therapy: a systematic review and meta-analysis. Clinical Cardiology. 2014;37:707–15. DOI: 10.1002/clc.22312
Sweeney MO, Wathen MS, Volosin K, et al. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the pacing fast VT reduces shock therapies (PainFREE Rx II) trial. Circulation. 2005;111(22):2898–905.
Daubert JP, Zareba W, Cannom DS, et al. Inappropriate implantable cardioverterdefibrillator shocks in MADIT II. Frequency, mechanisms, predictors, and survival impact. Journal of the American College of Cardiology. 2008;51:1357–1365 DOI: 10.1016/j.jacc.2007.09.073.
Gasparini M, Kloppe A, Lunati M, et al. Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations. European Journal of Heart Failure. 2018;20:1472–1481
Ploux S, Eschalier R, Whinnett ZI, et al. Electrical dyssynchrony induced by biventricular pacing: implications for patient selection and therapy improvement. Heart Rhythm. 2015;12(4):782–91.
Sharma PS, Vijayaraman P, Ellenbogen KA. Permanent His bundle pacing: shaping the future of physiological ventricular pacing. Nature reviews. Cardiology. 2020;17:22–36. DOI: 10.1038/s41569-019-0224-z.
Sharma PS, Naperkowski A, Bauch TD, et al. Permanent his bundle pacing for cardiac resynchronization therapy in patients with heart failure and right bundle branch block. Circulation. Arrhythmia and Electrophysiology. 2018;11:e006613. DOI: 10.1161/CIRCEP.118.006613.
Huang W, Su L, Wu S, et al. Benefits of permanent His bundle pacing combined with atrioventricular node ablation in atrial fibrillation patients with heart failure with both preserved and reduced left ventricular ejection fraction. Journal of the American Heart Association. 2017;6:e005309. DOI:10.1161/JAHA.116.005309.
Vijayaraman P, Subzposh FA, Naperkowski A. Atrioventricular node ablation and His bundle pacing Europace . 2017 Dec 1;19(suppl_4):iv10-iv16. DOI: 10.1093/europace/eux263.
Rademakers LM, van den Broek J, Op ’t Hof M, et al. Initial experience, feasibility and safety of permanent left bundle branch pacing: results from a prospective single-centre study. Netherlands Heart Journal. 2022;30:258–266. DOI:10.1007/s12471-021-01648-6.
Vijayaraman P, Subzposh FA, Naperkowski A, et al. Prospective evaluation of feasibility and electrophysiologic and echocardiographic characteristics of left bundle branch area pacing. Heart Rhythm. 2019;16:1774–1782. DOI:10.1016/j.hrthm.2019.05.011.
Pillai A, Kolominsky J, Koneru JN, et al. Atrioventricular junction ablation in patients with conduction system pacing leads: a comparison of His-bundle vs left bundle branch area pacing leads. Heart Rhythm. 2022;19:1116–1123. DOI:10.1016/j.hrthm.2022.03.1222.
Gerhard Hindricks, Tatjana Potpara, Nikolaos Dagres, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2020;00, 1-126. DOI:10.1093/eurheartj/ehaa612.
Michael Glikson, Jens Cosedis Nielsen, Mads Brix Kronborg, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. European Heart Journal. 2020;00, 1-94.
January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation. 2019;140:e125–51. DOI: 10.1161/CIR.0000000000000665.
Mina K. Chung, Kristen K. Patton, Chu-Pak Lau, et al. 2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure. Heart Rhythm. 2023 DOI:10.1016/j.hrthm.2023.03.1538.
Referanslar
H. Zulkifly, G.Y.H. Lip, D.A. Lane, Epidemiology of atrial fibrillation. The International Journal of Clinical Practice. 2018; e13070. DOI:10.1111/ijcp.13070.
Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. The American Journal of Cardiology. 2003;91:2D–8D. DOI: 10.1016/s0002-9149(02)03373-8.
Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;91:2D–8D. DOI: 10.1161/01.CIR.0000072767.89944.6E.
Deedwania PC, Lardizabal JA. Atrial fibrillation in heart failure: a comprehensive review. The American Journal of Medicine. 2010; 123: 198–204. DOI: 10.1016/j.amjmed.2009.06.033.
Wood MA, Brown-Mahoney C, Kay GN, et al. Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis. Circulation. 2000;101:1138-44 DOI: 10.1161/01.cir.101.10.1138.
Lara Kugler, Susanne Markendorf , Marta Bachmann, et al. Cardiac resynchronization therapy in the presence of total atrioventricular block reduces long-lasting atrial fibrillation episodes. Journal of Arrhythmia. 2022; Sep 7;38(5):723-729. DOI: 10.1002/joa3.12776.
Finn Akerström, Moisés Rodríguez Mañero, Marta Pachón, et al. Atrioventricular Junction Ablation In Atrial Fibrillation: Choosing The Right Patient And Pacing Device. Journal of Atrial Fibrillation. 2015; Aug 31;8(2):1253. DOI: 10.4022/jafib.1253.
Balijepalli RC, Lokuta AJ, Maertz NA, et al. Depletion of T-tubules and specific subcellular changes in sarcolemmal proteins in tachycardia-induced heart failure. Cardiovascular Research. 2003;59:67-77. DOI: 10.1016/s0008-6363(03)00325-0.
Selby DE, Palmer BM, LeWinter MM, et al. Tachycardia-induced diastolic dysfunction and resting tone in myocardium from patients with a normal ejection fraction. Journal of the American College of Cardiology. 2011;58:147-54 DOI: 10.1016/j.jacc.2010.10.069.
Gupta S, Figueredo VM. Tachycardia mediated cardiomyopathy: pathophysiology, mechanisms, clinical features and management. International Journal of Cardiology. 2014;172:40-6.
Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. The New England Journal of Medicine. 2002;347:1825–1833. DOI: 10.1056/021328.
Roy D, Talajic M, Nattel S, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. The New England Journal of Medicine. 2008;358:2667–2677. DOI: 10.1056/NEJMoa0708789.
Carlsson J, Miketic S, Windeler J, et al. Randomized trial of rater-control versus rhythm-control in persistent atrial fibrillation. Journal of the American College of Cardiology. 2003;41:1690. DOI: 10.1016/s0735-1097(03)00332-2.
Khan MN, Jais P, Cummings J, et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. The New England Journal of Medicine. 2008;359:1778–1785. DOI: 10.1056/NEJMoa0708234.
Marrouche NF, Brachmann J, Andresen D, et al. Catheter ablation for atrial fibrillation with heart failure. The New England Journal of Medicine. 2018;378:417–427. DOI: 10.1056/NEJMc1806519.
Cleland JGF, Keshavarzi F, Pellicori P, et al. Case selection for cardiac resynchronization in atrial fibrillation. Heart Failure Clinics. 2013;9: 461–74. DOI: 10.1016/j.hfc.2013.07.001
Erik O Udo 1, Nicolaas P A Zuithoff, Norbert M Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm. 2012 May;9(5):728-35. DOI: 10.1016/j.hrthm.2011.12.014.
Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. The American Journal of Cardiology. 2003;91:2D–8D.
Hikmet Yorgun, Uğur Canpolat, Yusuf Ziya Şener, et al. Acute and long-term outcomes of left-sided atrioventricular node ablation in patients with atrial fibrillation. Journal of Interventional Cardiac Electrophysiology. 2020 Dec;59(3):527-533. doi: 10.1007/s10840-019-00642-8.
Chatterjee NA, Upadhyay GA, Ellenbogen KA, et al. Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis and systematic review. Circulation: Arrhythmia and Electrophysiology. 2012;5:68–76. DOI: 10.1161/CIRCEP.111.967810.
Brignole M, Gianfranchi L, Menozzi C, et al. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study. Circulation. 1997;96:2617–2624. DOI: 10.1161/01.cir.96.8.2617.
Gasparini M, Leclercq C, Lunati M, et al. Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry). JACC Heart Failure. 2013 Dec;1(6):500-7.
Gasparini M, Auricchio A, Regoli F, et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. Journal of the American College of Cardiology. 2006;48:734–743. DOI: 10.1016/j.jacc.2006.03.056.
Scheinman MM, Morady F, Hess DS, et al. Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. The Journal of the American Medical Association. 1982;248:851-5.
Huang SK, Bharati S, Graham AR, et al. Closed chest catheter desiccation of the atrioventricular junction using radiofrequency energy-a new method of catheter ablation. Journal of the American College of Cardiology. 1987;9:349-58.
Sousa J, El-Atassi R, Rosenheck S, et al. Radiofrequency catheter ablation of the atrioventricular junction from the left ventricle. Circulation. 1991;84:567–571. DOI: 10.1161/01.cir.84.2.567.
Marshall HJ, Griffith MJ. Ablation of the atrioventricular junction: Technique, acute and long-term results in 115 consecutive patients. Europace. 1999; 1: 26–29. DOI: 10.1053/eupc.1998.0004.
Dilesh Patel, Emile G. Daoud Atrioventricular Junction Ablation for Atrial Fibrillation. Heart Failure Clinics. 12 2016;245–255.
Proclemer A, Facchin D, Pagnutti C, et al. Safety of pacemaker implantation prior to radiofrequency ablation of atrioventricular junction in a single session procedure. Pacing and Clinical Electrophysiology. 2000;23:998-1002. DOI: 10.1111/j.1540-8159.2000.tb00887.
Geelen P, Brugada J, Andries E, et al. Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction. Pacing and Clinical Electrophysiology. 1997;20(2 Pt 1):343–8.
Wang RX, Lee HC, Hodge DO, et al. Effect of pacing method on risk of sudden death after atrioventricular node ablation and pacemaker implantation in patients with atrial fibrillation. Heart Rhythm. 2013;10(5):696–701 DOI: 10.1016/j.hrthm.2013.01.021.
Szili-Torok T, Kimman GP, Theuns D, et al. Deterioration of left ventricular function following atrio-ventricular node ablation and right ventricular apical pacing in patients with permanent atrial fibrillation. Europace. 2002;4:61–65. DOI:10.1053/eupc.2001.0212.
Tops LF, Schalij MJ, Holman ER, et al. Right ventricular pacing can induce ventricular dyssynchrony in patients with atrial fibrillation after atrioventricular node ablation. Journal of the American College of Cardiology. 2006;48:1642–1648. DOI:10.1016/j.jacc.2006.05.072.
Rahul N Doshi, Emile G Daoud, Christopher Fellows, et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). Journal of cardiovascular electrophysiology. 2005 Nov;16(11):1160-5.
Suneet Mittal, Dan L Musat, Michael H Hoskins, et al. Clinical Outcomes After Ablation of the AV Junction in Patients With Atrial Fibrillation: Impact of Cardiac Resynchronization Therapy. Journal of the American Heart Association. 2017 Nov 27;6(12):e007270. DOI: 10.1161/JAHA.117.007270.
Kan Dong, Win-Kuang Shen, Brian D Powell, et al. Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy. Heart Rhythm. 2010Sep;7(9):1240-5. DOI: 10.1016/j.hrthm.2010.02.011.
Michele Brignole, Francesco Pentimalli, Pietro Palmisano, et al. AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. European heart journal. 2021 Dec 7;42(46):4731-4739. DOI: 10.1093/eurheartj/ehab569.
Michele Brignole, Evgeny Pokushalov, Francesco Pentimalli, et al. A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS. European heart journal. 2018 Dec 1;39(45):3999-4008. DOI: 10.1093/eurheartj/ehy555.
Dickstein K, Normand C, Auricchio A, et al. CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients—who is doing what to whom and how? European Journal of Heart Failure. 2018;20:1039–1051. DOI: 10.1002/ejhf.1142.
Santini M, Gasparini M, Landolina M, et al. Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators. Journal of the American College of Cardiology. 2011;57:167–172. DOI: 10.1016/j.jacc.2010.08.624.
Mustafa U, Atkins J, Mina G, et al. Outcomes of cardiac resynchronisation therapy in patients with heart failure with atrial fibrillation: a systematic review and meta-analysis of observational studies. Open Heart. 2019;6:1–12 DOI: 10.1136/openhrt-2018-000937
Ousdigian KT, Borek PP, Koehler JL, et al. The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality. Circulation. Arrhythmia and electrophysiology. 2014;7:370–376. DOI: 10.1161/CIRCEP.113.001212.
Kamath GS, Cotiga D, Koneru JN, et al. The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy. Journal of the American College of Cardiology. 2009;53:1050–1055.
Antonio Hernández-Madrid, Domenico Facchin, Ruth Nicholson Klepfer, et al. Device pacing diagnostics overestimate effective cardiac resynchronization therapy pacing results of the hOLter for Efficacy analysis of CRT (OLÉ CRT) study. Heart Rhythm. 2017Apr;14(4):541-547. DOI: 10.1016/j.hrthm.2017.01.022.
Yoga Waranugraha, Ardian Rizal, Dion Setiawan, et al. The Benefit of Atrioventricular Junction Ablation for Permanent Atrial Fibrillation and Heart Failure Patients Receiving Cardiac Resynchronization Therapy: An Updated Systematic Review and Meta-analysis. Indian Pacing and Electrophysiology Journal. 2021 Mar-Apr;21(2):101-111. DOI: 10.1016/j.ipej.2020.12.005.
Yin J, Hu H, Wang Y, et al. Effects of atrioventricular nodal ablation on permanent atrial fibrillation patients with cardiac resynchronization therapy: a systematic review and meta-analysis. Clinical Cardiology. 2014;37:707–15. DOI: 10.1002/clc.22312
Sweeney MO, Wathen MS, Volosin K, et al. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the pacing fast VT reduces shock therapies (PainFREE Rx II) trial. Circulation. 2005;111(22):2898–905.
Daubert JP, Zareba W, Cannom DS, et al. Inappropriate implantable cardioverterdefibrillator shocks in MADIT II. Frequency, mechanisms, predictors, and survival impact. Journal of the American College of Cardiology. 2008;51:1357–1365 DOI: 10.1016/j.jacc.2007.09.073.
Gasparini M, Kloppe A, Lunati M, et al. Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations. European Journal of Heart Failure. 2018;20:1472–1481
Ploux S, Eschalier R, Whinnett ZI, et al. Electrical dyssynchrony induced by biventricular pacing: implications for patient selection and therapy improvement. Heart Rhythm. 2015;12(4):782–91.
Sharma PS, Vijayaraman P, Ellenbogen KA. Permanent His bundle pacing: shaping the future of physiological ventricular pacing. Nature reviews. Cardiology. 2020;17:22–36. DOI: 10.1038/s41569-019-0224-z.
Sharma PS, Naperkowski A, Bauch TD, et al. Permanent his bundle pacing for cardiac resynchronization therapy in patients with heart failure and right bundle branch block. Circulation. Arrhythmia and Electrophysiology. 2018;11:e006613. DOI: 10.1161/CIRCEP.118.006613.
Huang W, Su L, Wu S, et al. Benefits of permanent His bundle pacing combined with atrioventricular node ablation in atrial fibrillation patients with heart failure with both preserved and reduced left ventricular ejection fraction. Journal of the American Heart Association. 2017;6:e005309. DOI:10.1161/JAHA.116.005309.
Vijayaraman P, Subzposh FA, Naperkowski A. Atrioventricular node ablation and His bundle pacing Europace . 2017 Dec 1;19(suppl_4):iv10-iv16. DOI: 10.1093/europace/eux263.
Rademakers LM, van den Broek J, Op ’t Hof M, et al. Initial experience, feasibility and safety of permanent left bundle branch pacing: results from a prospective single-centre study. Netherlands Heart Journal. 2022;30:258–266. DOI:10.1007/s12471-021-01648-6.
Vijayaraman P, Subzposh FA, Naperkowski A, et al. Prospective evaluation of feasibility and electrophysiologic and echocardiographic characteristics of left bundle branch area pacing. Heart Rhythm. 2019;16:1774–1782. DOI:10.1016/j.hrthm.2019.05.011.
Pillai A, Kolominsky J, Koneru JN, et al. Atrioventricular junction ablation in patients with conduction system pacing leads: a comparison of His-bundle vs left bundle branch area pacing leads. Heart Rhythm. 2022;19:1116–1123. DOI:10.1016/j.hrthm.2022.03.1222.
Gerhard Hindricks, Tatjana Potpara, Nikolaos Dagres, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2020;00, 1-126. DOI:10.1093/eurheartj/ehaa612.
Michael Glikson, Jens Cosedis Nielsen, Mads Brix Kronborg, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. European Heart Journal. 2020;00, 1-94.
January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation. 2019;140:e125–51. DOI: 10.1161/CIR.0000000000000665.
Mina K. Chung, Kristen K. Patton, Chu-Pak Lau, et al. 2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure. Heart Rhythm. 2023 DOI:10.1016/j.hrthm.2023.03.1538.
